![Michael J. Green](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Michael J. Green
Direttore/Membro del Consiglio presso Radio Free Asia
Posizioni attive di Michael J. Green
Società | Posizione | Inizio | Fine |
---|---|---|---|
Radio Free Asia
![]() Radio Free Asia Telecommunications EquipmentElectronic Technology Radio Free Asia broadcasts online news, information and commentary. It provides a forum for a variety of opinions and voices from within these Asian countries. The company was founded in March 12, 1996 and is headquartered in Washington, DC. | Direttore/Membro del Consiglio | - | - |
Storia della carriera di Michael J. Green
Precedenti posizioni note di Michael J. Green
Società | Posizione | Inizio | Fine |
---|---|---|---|
Celera Group
![]() Celera Group Pharmaceuticals: MajorHealth Technology Celera Group provides molecular diagnostics using proprietary genomics and proteomics discovery platforms to identify and validate novel diagnostic markers and to develop diagnostic products based on these markers. These diagnostic products are used to predict disease risk and optimize therapy selection, monitoring and patient outcome. The company was founded in May, 1998 and is located in Rockville, MD | Corporate Officer/Principal | - | - |
Trega Biosciences, Inc.
![]() Trega Biosciences, Inc. BiotechnologyHealth Technology Trega Biosciences, Inc. was a drug discovery company, utilizing combinatorial chemistry and other technologies to pursue the discovery of novel, small-molecule drug therapies. The company leveraged its technology platform by entering into pharmaceutical alliances, enabling partners to access its technologies in exchange for licensing fees and potential milestone payments and royalties or by establishing joint-discovery alliances with biotechnology companies. The company used its drug discovery technologies in its internal development programs. It was headquartered in San Diego, CA. The compnay was acquired by LION bioscience AG | Corporate Officer/Principal | - | - |
Axys Pharmaceuticals, Inc.
![]() Axys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Axys Pharmaceuticals, Inc. engages in the development of integrated drugs. The company is headquartered in South San Francisco, CA. | Corporate Officer/Principal | - | - |
Virobay, Inc.
![]() Virobay, Inc. Pharmaceuticals: MajorHealth Technology Virobay, Inc. develops protease inhibitors for the treatment of neuropathic pain, cancer, autoimmune and liver diseases. It utilize cysteine cathepsin platform for the development and commercialization of novel drugs. The firm's research & development activities focuses on neuropathic pain, autoimmune diseases and liver fibrosis. The company was founded by Robert F. G. Booth on May 18, 2006 and is headquartered in Menlo Park, CA. | Direttore Tecnico/Scientifico/R&S | 01/01/2006 | - |
Formazione di Michael J. Green
The University of Sheffield | Doctorate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 6 |
Regno Unito | 2 |
Posizioni
Corporate Officer/Principal | 3 |
Chief Tech/Sci/R&D Officer | 1 |
Doctorate Degree | 1 |
Settori
Health Technology | 5 |
Consumer Services | 2 |
Electronic Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 5 |
---|---|
Virobay, Inc.
![]() Virobay, Inc. Pharmaceuticals: MajorHealth Technology Virobay, Inc. develops protease inhibitors for the treatment of neuropathic pain, cancer, autoimmune and liver diseases. It utilize cysteine cathepsin platform for the development and commercialization of novel drugs. The firm's research & development activities focuses on neuropathic pain, autoimmune diseases and liver fibrosis. The company was founded by Robert F. G. Booth on May 18, 2006 and is headquartered in Menlo Park, CA. | Health Technology |
Trega Biosciences, Inc.
![]() Trega Biosciences, Inc. BiotechnologyHealth Technology Trega Biosciences, Inc. was a drug discovery company, utilizing combinatorial chemistry and other technologies to pursue the discovery of novel, small-molecule drug therapies. The company leveraged its technology platform by entering into pharmaceutical alliances, enabling partners to access its technologies in exchange for licensing fees and potential milestone payments and royalties or by establishing joint-discovery alliances with biotechnology companies. The company used its drug discovery technologies in its internal development programs. It was headquartered in San Diego, CA. The compnay was acquired by LION bioscience AG | Health Technology |
Axys Pharmaceuticals, Inc.
![]() Axys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Axys Pharmaceuticals, Inc. engages in the development of integrated drugs. The company is headquartered in South San Francisco, CA. | Health Technology |
Celera Group
![]() Celera Group Pharmaceuticals: MajorHealth Technology Celera Group provides molecular diagnostics using proprietary genomics and proteomics discovery platforms to identify and validate novel diagnostic markers and to develop diagnostic products based on these markers. These diagnostic products are used to predict disease risk and optimize therapy selection, monitoring and patient outcome. The company was founded in May, 1998 and is located in Rockville, MD | Health Technology |
Radio Free Asia
![]() Radio Free Asia Telecommunications EquipmentElectronic Technology Radio Free Asia broadcasts online news, information and commentary. It provides a forum for a variety of opinions and voices from within these Asian countries. The company was founded in March 12, 1996 and is headquartered in Washington, DC. | Electronic Technology |
- Borsa valori
- Insiders
- Michael J. Green
- Esperienza